AI tool PIONEER transforms precision medicine
Cornell Chronicle - 25-Nov-2024Transforming treatments with AI-driven insights into protein interactions and disease
Join the club for FREE to access the whole archive and other member benefits.
Transforming treatments with AI-driven insights into protein interactions and disease
These tools help surgeons plan better, reduce risks, and adapt quickly
Targeted drug delivery and immune boost for personalized cancer therapy
The system will use genetic testing to identify infections quickly
Tailored drug dosing could reduce harmful reactions for cancer patients
New funding accelerates AI advancements for precision medicine
Clinical trial shows treatment extends survival for patients with advanced lung cancer by over 40%
Breakthrough for the rarest of rare genetic diseases that affect only a few patients
Programmable mRNA tech promise precise & safe treatment for disease and age-related conditions
Fewer doses, better taste & improved adherence for rare diseases and beyond
Almost 4 million differences might be linked to disease risk, leading to targeted treatments
Project could lead to a brighter future for heart patients across Europe
This could lead to more personalised treatment plans and better outcomes
Sano's software pinpoints the perfect treatment match for each patient
Provides oncologists with a precise tumor genetic map for selecting treatments
Silicon Valley startup uses personalized data and AI twin to reverse type 2 diabetes and obesity
Company's "cell-free DNA platform" can detect unexplored cell-free DNA fragments
Government funding to fuel innovation and growth in the life science sector.
Company is transforming healthcare and enabling personalised medicine
Unlocking the secrets of cancer and genetic diseases with nanopore sequencing
CurifyLabs' pharma kit streamlines the production of tailored medications
Method can accurately predict your age, smoking status, and disease risk
Dostarlimab with 100% success rate in early trials offers hope for bowel cancer patients
Algocyte integrates data for personalised precision medicine
Lead program targets TRPV4, an ion channel that is involved in several diseases
The trial could help to match right treatment to people with rare cancers
Innovative technology combines synthetic biology, genomics, and machine learning to transform the way diseases are diagnosed and treated
Pressure-sensing innovation for flawless pharmaceutical 3D printing
Personalized T-cell therapy for untreatable cancers - further studies needed to test the dose and effectiveness
Chemotherapy treats patients but the lethal effect could be gotten down by preliminary testing
NHS to roll out genetic test that is currently able to match 40 drugs to patient's genetic code
Identifying faulty genes and matching cancer patients to potential experimential therapies
Technology suitable for meeting the lab requirements to deliver the service
Personalized porous tablets improve bioavailability of the drug and are much safer
Early but promising results with genomics in diagnosis and treatment of macular degeneration
A landmark strategy towards integrating personalised treatments in routine cancer care
Risk prediction and best therapy for a specific patient is a future possibility
Extreme personalised medicine realises there is no such thing as an average cell
Doctors from Boston sequenced in detail whole genome of Mila and found the disease-causing mutation
40% of patients with CF don't respond to treatment because of rare mutations
Will tell us about the new drugs that can cause blindness
Polypharmacy burden could be ended with personalized medicine breakthrough
DNA tests might identify ‘invisible population’ who are not currently seen as in danger
Could reduce time and cost of DNA testing
Lots more detail needed - how much, what will be tested for, how will results be interpreted?
From surgical planning and implants, to patient-specific pills
New web tool analyses over 49000 DNA markers to calculate risk for various diseases
87 percent of participants in worldwide genomics research of European descent.
Project to uncover the genetic causes of diseases began in 2012.
Handheld device developed by the company Oxford Nanopore.
Foundation Medicine's test for patients with advanced or widely spread cancers.
Genetic test is a faster, less expensive treatment method for men with advanced prostate cancer
FDA approved in 2017, Kymriah is entirely customised to the individual patient.
New drug custom-printing method would allow pharmacists to customise for dosage, for your own personal biology, or even to combine many pills into one dose.
Professor Dame Sally Davies envisions millions of patients having their DNA tested routinely.
The way each person processes medication is unique.
Aptamer-based sensors can track levels of small molecules in mobile rats.
A decade after the Human Genome Project was declared complete the cost to sequence DNA has plummeted roughly a millionfold.
Improving Outcomes Through Personalised Medicine report launched at Health and Innovation Expo 2016.
100,000 Genomes Project is sequencing genomes from patients with rare diseases, cancers and infectious diseases.
Different clinical circumstances call for different types of timed release of drugs.
MIT develops portable pharmaceutical manufacturing system that can be reconfigured to produce a variety of drugs on demand.
All-Party Parliamentary Group (APPG) on Personalised Medicine has launched at the House of Commons.
SAP Foundation for Health and the SAP Medical Research Insights solution built on the HANA platform.
A solid overview of personalised medicine including genetic variations, genomic testing, -omics technologies and biomarkers.
Jipmer hospital to regularly use pharmacogenomics testing of drug-related proteins.
Aprecia launches first FDA approved 3D-printed drug. The epilepsy pill could lead the way to personalised medicines being manufactured close to the point of care. Once drug manufacturing is controlled by digital specifications, instead of bulk production
More than 5,000 patients with metastatic disease recruited from four large multi-centre global clinical trials. Some patients who would receive no benefit could skip three months of unnecessary treatment.
Need to overcome siloed and unstructured health data. Technology can help to synthesize information for healthcare professionals to enable better treatment decisions by clinicians. SAP partnering with ASCO to provide real-time clinical insights for cancer
More and more investment in medical technology.
Blood tests to be offered to close relatives of people found to have familial hypercholesterolaemia.